Wednesday, September 9, 2020

Pfizer, BioNTech Say MRNA-based Vaccine Candidate Protected Rhesus Macaques In Preclinical Studies

Pfizer Inc. (PFE) and BioNTech SE (BNTX) on Wednesday announced preliminary preclinical data in mouse and non-human primate models from their BNT162b2 mRNA-based vaccine program against SARS-CoV-2, the virus that causes COVID-19, or the coronavirus disease.

from RTT - Biotech https://ift.tt/33dt6m1
via IFTTT

No comments:

Post a Comment